{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:17:44Z","timestamp":1787959064344,"version":"build-2784847793"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Several psychotherapy protocols have been evaluated as adjuncts to pharmacotherapy for patients with bipolar disorder (BD). Little is known about their comparative effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the effectiveness of 2 types of group psychotherapy, skill-oriented, material-based cognitive behavioral therapy (SEKT) and supportive, patient-centered, emotion-focused therapy (FEST), to prevent relapse in patients with euthymic BD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      This was a large, observer-blind, randomized clinical trial conducted over 18 months (posttreatment after 6 months; follow-up at 12 and 18 months). In addition to psychiatric care as usual (including mood-stabilizing medication), each participant at 9 clinical outpatient units in Germany received 24 hours of group psychotherapy over 4, full-day sessions spread over 5 months. Patients with euthymic BD type 1 (BD 1) or BD type 2 (BD 2) between the ages of 18 and 50 years were randomly assigned to 1 of 2 forms of psychotherapy, SEKT or FEST. Independent clinicians blinded to patient grouping performed assessments using structured interviews (Structured Clinical Interview for\n                      <jats:italic>DSM<\/jats:italic>\n                      Disorders and Longitudinal Interval Follow-Up Evaluation) and self-rating and clinician rating for inclusion criteria and outcome. Kaplan-Meier survival curves were calculated for time to relapse. Cox proportional hazards statistics and propensity score matching were calculated for the multivariate analysis. Study data were analyzed from March 2020 to September 2022.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>SEKT intervention is a structured cognitive behavioral therapy integrating elements of interpersonal social rhythm therapy, and of mindfulness-based cognitive therapy. FEST psychotherapy has its roots in emotion-focused, supportive, and nondirective therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Recurrence of a new affective episode assessed by blinded interviewer with the LIFE interview. In addition, self-rating and clinician rating of depressive and mania symptoms as well as level of social functioning were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 348 screened referrals, 305 patients (median [IQR] age, 34 [18-50] years; 162 male [53%]) with euthymic BD 1 or BD 2 were included in the study. A total of 207 patients (68%) had BD 1, 98 (32%) had BD 2, and 278 (91%) received psychiatric care. Both therapies were equally effective in preventing recurrence of a new episode. Outcome (higher rate of new episodes) was not predicted by kind of treatment (SEKT: 69 [49%] relapse; FEST: 63 [46%] relapse) but was predicted by BD 2, comorbidity, attending all sessions, and the interaction of type of treatment by BD 1 or 2. Patients with BD 2 had the highest rate of relapse (60 [61%] relapse), in particular, when treated by SEKT (39 [70%] relapse).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Results of this randomized clinical trial revealed  that a structured, skill-oriented, material-based cognitive behavioral therapy (SEKT) and a supportive, patient-centered, emotion-focused therapy (FEST) were equally effective in preventing relapse of affective episodes when delivered in a new, intensive group format. Additionally, there were baseline factors, in particular BD 2, that influenced outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02506322\">NCT02506322<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2024.1310","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:04:47Z","timestamp":1717589087000},"page":"855","source":"Crossref","is-referenced-by-count":11,"title":["Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder"],"prefix":"10.1001","volume":"81","author":[{"given":"Martin","family":"Hautzinger","sequence":"first","affiliation":[{"name":"Department of Psychology, Clinical Psychology and Psychotherapy, Eberhard Karls University Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"A2 BipoLife Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"yoi240027r1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).","volume":"163","author":"Perlis","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi240027r2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1192\/bjp.bp.107.037887","article-title":"Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials.","volume":"192","author":"Beynon","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"11","key":"yoi240027r3","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1176\/appi.ajp.2008.08040488","article-title":"Adjunctive psychotherapy for bipolar disorder: state of the evidence.","volume":"165","author":"Miklowitz","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"3","key":"yoi240027r4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/wps.20149","article-title":"The promise of cognitive behavior therapy for treatment of severe mental disorders: a review of recent developments.","volume":"13","author":"Thase","year":"2014","journal-title":"World Psychiatry"},{"issue":"1","key":"yoi240027r5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4088\/JCP.08r04559yel","article-title":"The efficacy of cognitive-behavioral therapy in bipolar disorder: a quantitative meta-analysis.","volume":"71","author":"Szentagotai","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"yoi240027r6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/pcn.12399","article-title":"Effectiveness of cognitive behavioral therapy in treating bipolar disorder: an updated meta-analysis with randomized controlled trials.","volume":"70","author":"Ye","year":"2016","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"yoi240027r7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176849","article-title":"Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: a meta-analysis of randomized controlled trials.","volume":"12","author":"Chiang","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"yoi240027r8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S1461145706006900","article-title":"A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders.","volume":"10","author":"Scott","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"yoi240027r9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.4088\/JCP.11m07343","article-title":"A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME].","volume":"73","author":"Parikh","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"yoi240027r10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamapsychiatry.2020.2993","article-title":"Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis.","volume":"78","author":"Miklowitz","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"yoi240027r11","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1017\/S0033291711002522","article-title":"Cognitive behavioral therapy and supportive therapy for bipolar disorders: relapse rates for treatment period and 2-year follow-up.","volume":"42","author":"Meyer","year":"2012","journal-title":"Psychol Med"},{"issue":"1","key":"yoi240027r12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1186\/s13063-020-04755-8","article-title":"Adjuvant psychotherapy in early stage bipolar disorder: study protocol for a randomized controlled trial.","volume":"21","author":"Stamm","year":"2020","journal-title":"Trials"},{"issue":"6","key":"yoi240027r13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/archpsyc.1987.01800180050009","article-title":"The longitudinal interval follow-up evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies.","volume":"44","author":"Keller","year":"1987","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"yoi240027r14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.","volume":"54","author":"Rush","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"5","key":"yoi240027r15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity, and sensitivity.","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"issue":"2-3","key":"yoi240027r16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0165-0327(98)00018-4","article-title":"Rating scales for mania: is self-rating reliable?","volume":"50","author":"Altman","year":"1998","journal-title":"J Affect Disord"},{"issue":"1","key":"yoi240027r17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-0179-3-5","article-title":"Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder.","volume":"3","author":"Rosa","year":"2007","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"1","key":"yoi240027r20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score.","volume":"39","author":"Rosenbaum","year":"1985","journal-title":"Am Stat"},{"issue":"4","key":"yoi240027r21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cpr.2012.01.003","article-title":"The efficacy of nondirective supportive therapy for adult depression: a meta-analysis.","volume":"32","author":"Cuijpers","year":"2012","journal-title":"Clin Psychol Rev"},{"issue":"5","key":"yoi240027r22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1399-5618.2009.00724.x","article-title":"Psychological therapies in bipolar disorder\u2014the effect of illness history on relapse prevention: a systematic review.","volume":"11","author":"Lam","year":"2009","journal-title":"Bipolar Disord"},{"issue":"2","key":"yoi240027r23","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16m11027","article-title":"Psychotherapy alone and combined with medication as treatments for Bipolar II Depression: a randomized controlled trial.","volume":"79","author":"Swartz","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"yoi240027r24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00278-022-00634-6","article-title":"Consideration of comorbidities in research on the effectiveness of depression treatment.","volume":"68","author":"Trinkler","year":"2023","journal-title":"Die Psychotherapie"},{"key":"yoi240027r18","volume-title":"Bipolar Disorder: A Cognitive-Behavioral Treatment Program","author":"Meyer","year":"2013","edition":"2nd ed"},{"key":"yoi240027r19","doi-asserted-by":"crossref","DOI":"10.1093\/med-psych\/9780197635803.001.0001","volume-title":"Brief Supportive Psychotherapy: A Treatment Manual and Clinical Approach","author":"Markowitz","year":"2022"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2819406\/jamapsychiatry_hautzinger_2024_oi_240027_1727101468.94689.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T17:37:17Z","timestamp":1727285837000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2819406"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.1310","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}